Daiichi Sankyo
May 09, 2012 at 17:39 | Source: Moneycontrol.com
May 09, 2012 at 15:36 | Source: Reuters
May 09, 2012 at 14:30 | Source: Moneycontrol.com
Apr 25, 2012 at 16:26 | Source: Reuters
Apr 02, 2012 at 14:26 | Source: Reuters
Feb 24, 2012 at 12:34 | Source: Moneycontrol.com
Videos »
Photos »
/ 
News across the web »
May 20, 2012 at 23:01 | Source: The Hindu BusinessLine
May 11, 2012 at 18:52 | Source: The Hindu BusinessLine
May 11, 2012 at 16:26 | Source: Business Today
May 09, 2012 at 06:32 | Source: Economic Times
May 08, 2012 at 02:31 | Source: Economic Times
Interact & exchange stock tips & market info »
Related News »
ArQule, Inc. (Nasdaq: ARQL) and Daiichi Sankyo, Co., Ltd. (TSE 4568) today announced that recruitment of patients has been completed in the randomized, double-blind, controlled Phase 3 MARQUEE pivotal trial of their investigational selective c ...
May 19, 2012 at 06:24 | Source: News-Medical.Net
May 22, 2012 (M2 PRESSWIRE via COMTEX) -- The National Cancer Center (Chief Director: Dr. Tomomitsu Hotta) and Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo; President & Representative Director: Joji Nakayama) have agreed to form a ...
May 22, 2012 at 13:51 | Source: TMCnet
To mark this year's World Hypertension Day, Daiichi Sankyo Europe has announced a website for patients offering more information about hypertension management and treatment. http://www.hypertensioncare.eu is now available to patients and physicians across ...
May 17, 2012 at 02:58 | Source: PressePortal.de
Daiichi Sankyo Co., Ltd. - SWOT Analysis company profile is the essential source for top-level company data and information. Daiichi Sankyo Co., Ltd. - SWOT Analysis examines the company's key business structure and operations, history and products, and ...
May 15, 2012 at 15:40 | Source: Transworld News
Tokyo, Japan (May 22, 2012) - The National Cancer Center (Chief Director: Dr. Tomomitsu Hotta) and Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo; President & Representative Director: Joji Nakayama) have agreed to form a comprehensive research ...
May 21, 2012 at 23:46 | Source: 4-traders (press release)
ArQule, Inc. (Nasdaq:ARQL - News) and Daiichi Sankyo, Co., Ltd. (TSE 4568) today announced that recruitment of patients has been completed in the randomized, double-blind, controlled Phase 3 MARQUEE pivotal trial of their investigational ...
May 18, 2012 at 11:25 | Source: Yahoo Finance
MELBOURNE, AUSTRALIA — Biota Holdings Limited (ASX: BTA) today announced that Daiichi Sankyo Co., Ltd. have provided written confirmation that Inavir® gross sales were JPY8.7bn and indicative royalties were $3.4 million for the three months ...
May 10, 2012 at 23:59 | Source: msnbc.com
But they often do not. Drugmaker Daiichi Sankyo, for example, stuck to its offer price for India’s Ranbaxy even as the target’s stock plunged after the Lehman shock, and as the Indian drugmaker faced a US import ban. Daiichi has not made as much money ...
May 24, 2012 at 18:42 | Source: Financial Times
The results were welcome news for Ranbaxy's Japanese owner, Daiichi Sankyo, which has seen the Indian firm's earnings hit by a string of US regulatory setbacks since it paid $4.6 billion in 2008 for a controlling stake. Ranbaxy Laboratories said ...
May 25, 2012 at 23:56 | Source: YAHOO!
Cipher will also get a royalty on net sales from Ranbaxy - majority owned by Japanese company Daiichi Sankyo. The U.S. acne treatment market was worth about $400 million in 2011. Absorica will be the flagship brand for Ranbaxy's specialised ...
May 28, 2012 at 11:06 | Source: Reuters India